Cargando…

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

Detalles Bibliográficos
Autores principales:	Morré, D. James, Hostetler, Brandon, Taggart, David J., Morré, Dorothy M., Musk, A. W., Robinson, Bruce W. S., Creaney, Jenette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762167/ https://www.ncbi.nlm.nih.gov/pubmed/26903779 http://dx.doi.org/10.1186/s12014-016-9105-1

Ejemplares similares

ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)

ENOX2 Target for the Anticancer Isoflavone ME-143
por: Morré, D. James, et al.
Publicado: (2014)

Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2017)

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma
por: Robinson, Cleo, et al.
Publicado: (2015)

Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2011)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo
por: Greening, David W., et al.
Publicado: (2016)

Association of Biomarker Levels with Severity of Asbestos-Related Diseases
por: Park, Eun-Kee, et al.
Publicado: (2012)

How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
por: Robinson, Bruce W.S., et al.
Publicado: (2022)

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
por: Creaney, Jenette, et al.
Publicado: (2013)

Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans
por: Robinson, Cleo, et al.
Publicado: (2014)

Erratum: Asbestos exposure and autoantibody titers
por: Lee, Eunsoo, et al.
Publicado: (2021)

MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
por: Birnie, Kimberly A., et al.
Publicado: (2019)

Hyaluronic acid in viscous malignant mesothelioma pleural effusion
por: Cheah, Hui Min, et al.
Publicado: (2020)

Calretinin as a blood-based biomarker for mesothelioma
por: Johnen, Georg, et al.
Publicado: (2017)

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
por: Creaney, J, et al.
Publicado: (2001)

Erratum to: Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma
por: Ömeroğlu Şimşek, Gökçen, et al.
Publicado: (2022)

Primary malignant mesothelioma of the diaphragm with liver invasion: A case report and review of literature: Erratum
Publicado: (2019)

Erratum: Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea
por: Kim, Yoon Kyung, et al.
Publicado: (2016)

Malignant Mesothelioma after Household Exposure to Asbestos
por: Saba, Raya, et al.
Publicado: (2013)

Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019)

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2019)

An Overview of Asbestos and Malignant Pleural Mesothelioma: An Iranian Perspective
por: Emami, Habib, et al.
Publicado: (2017)

Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report
Publicado: (2021)

Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma
por: Fan, Xiyong, et al.
Publicado: (2019)

Chrysotile Asbestos and Mesothelioma
por: Lemen, Richard A.
Publicado: (2010)

Erratum to: Ectopic ACTH secretion associated to a well-differentiated peritoneal mesothelioma
por: Mendoza, Carmen F., et al.
Publicado: (2015)

Malignant mesothelioma of the tunica vaginalis of the testis without exposure to asbestos
por: Goel, Ashish, et al.
Publicado: (2008)

Occupational exposure to asbestos and mortality among asbestos removal workers: a Poisson regression analysis
por: Frost, G, et al.
Publicado: (2008)

Asbestos and Mesothelioma: A Comment
por: Jargin, Sergei V.
Publicado: (2018)

Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos
por: Magnani, C, et al.
Publicado: (2000)

Malignant Pleural and Peritoneal Mesothelioma Consequential to Brief Indirect Asbestos Exposure
por: Singhal, Bharati, et al.
Publicado: (2014)

Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
por: Grzankowski, Kassondra S., et al.
Publicado: (2014)

The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure
por: Marinaccio, Alessandro, et al.
Publicado: (2018)

Incidence of malignant mesothelioma and asbestos exposure in the Emilia-Romagna region, Italy
por: Mangone, Lucia, et al.
Publicado: (2022)

Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries
por: Gariazzo, Claudio, et al.
Publicado: (2023)

Cancer prevention trial of a synergistic mixture of green tea concentrate plus Capsicum (CAPSOL-T) in a random population of subjects ages 40-84
por: Hanau, Claudia, et al.
Publicado: (2014)

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_tkkcovuq46fof9ckmaf0nsednv